Cm Management, LLC Coherus Bio Sciences, Inc. Transaction History

Cm Management, LLC

$97.7 Million
Q2 2025

A detailed history of Cm Management, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Cm Management, LLC holds 2,250,000 shares of CHRS stock, worth $3.08 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares

2,250,000

Previous 2,147,500 4.77%

Holding current value

$3.08 Million

Previous $1.74 Million 5.58%

% of portfolio

1.68%

Previous 1.9%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$0.72 - $1.12 $73,800 - $114,800	102,500 Added 4.77%	2,250,000 $1.64 Million
Q1 2025 May 09, 2025	BUY	$0.81 - $1.66 $78,975 - $161,850	97,500 Added 4.76%	2,147,500 $1.74 Million
Q4 2024 Feb 07, 2025	BUY	$0.67 - $1.71 $33,500 - $85,500	50,000 Added 2.5%	2,050,000 $2.83 Million
Q3 2024 Nov 12, 2024	BUY	$0.99 - $1.8 $891,000 - $1.62 Million	900,000 Added 81.82%	2,000,000 $2.08 Million
Q2 2024 Aug 01, 2024	BUY	$1.58 - $2.51 $158,000 - $250,999	100,000 Added 10.0%	1,100,000 $1.9 Million
Q1 2024 May 14, 2024	BUY	$2.02 - $3.14 $355,520 - $552,640	176,000 Added 21.36%	1,000,000 $2.39 Million
Q4 2023 Feb 12, 2024	BUY	$1.59 - $3.85 $438,840 - $1.06 Million	276,000 Added 50.36%	824,000 $2.74 Million
Q3 2023 Nov 07, 2023	BUY	$3.74 - $5.45 $366,520 - $534,100	98,000 Added 21.78%	548,000 $2.05 Million
Q2 2023 Aug 04, 2023	BUY	$3.79 - $8.3 $947,500 - $2.08 Million	250,000 Added 125.0%	450,000 $1.92 Million
Q1 2023 May 08, 2023	BUY	$5.89 - $10.52 $147,250 - $263,000	25,000 Added 14.29%	200,000 $1.37 Million
Q4 2022 Feb 09, 2023	SELL	$5.69 - $10.07 $142,250 - $251,750	-25,000 Reduced 12.5%	175,000 $1.39 Million
Q2 2022 Aug 08, 2022	BUY	$5.86 - $13.23 $293,000 - $661,500	50,000 Added 33.33%	200,000 $1.45 Million
Q1 2022 May 09, 2022	BUY	$10.92 - $16.41 $273,000 - $410,250	25,000 Added 20.0%	150,000 $1.94 Million
Q3 2021 Nov 08, 2021	BUY	$12.68 - $17.79 $317,000 - $444,750	25,000 Added 25.0%	125,000 $2.01 Million
Q2 2021 Aug 10, 2021	BUY	$12.95 - $15.41 $323,750 - $385,250	25,000 Added 33.33%	100,000 $1.38 Million
Q1 2021 May 12, 2021	BUY	$14.42 - $21.39 $216,300 - $320,850	15,000 Added 25.0%	75,000 $1.1 Million
Q4 2020 Feb 04, 2021	BUY	$16.56 - $18.94 $993,599 - $1.14 Million	60,000 New	60,000 $1.04 Million

Others Institutions Holding CHRS

# of Institutions

119

Shares Held

58.2M

Call Options Held

89.3K

Put Options Held

31K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $106M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.

Account

Cm Management, LLC Coherus Bio Sciences, Inc. Transaction History